Case reportUstekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
Under a Creative Commons license
open access
Key words
psoriasis
fissured tongue
palmoplantar psoriasis
psoriatic glossitis
ustekinumab
Abbreviations used
DLQI
Dermatology Life Quality Index
PASI
Psoriasis Area Severity Index
QoL
quality of life
Cited by (0)
Funding sources: None.
Conflicts of interest: Dr Chiricozzi has been an advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for Abbvie, Biogen, Leo Pharma, Lilly, Novartis, UCB-Pharma, Sanofi, and Janssen. Prof Romanelli has been an advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for Abbvie, Abiogen, Almirall, Lilly, Mundipharma, Novartis, Leo Pharma, Smith & Nephew, Urgo Medical, Hartman, and Sanofi. Drs Tonini, Zanframundo, Marchetti, and Panduri have no conflicts to disclose.
© 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.